TABLE 1.
Combined Cohort (n = 11) | Surgical Cohort (n = 10) | P | |
---|---|---|---|
Demographic Characteristics | |||
Age, yr | |||
Mean (range) | 31 (19–44) | 33 (18–66) | 0.68 |
Sex | |||
% Male | 36 | 30 | 0.88 |
Race (%) | |||
Black | 5 (45) | 6 (60) | |
White | 3 (27) | 3 (30) | |
Hispanic | 1 (9) | 0 (0) | |
Asian/Pacific Islander | 1 (9) | 0 (0) | |
Other | 1 (9) | 1 (10) | |
BMI, kg/m2 | |||
Mean (range) | 36 (20–56) | 35.5 (21.5–50) | 0.92 |
Comorbidities (%) | |||
Hypertension | 4 (36) | 4 (40) | 0.26 |
Diabetes mellitus | 1 (9) | 2 (20) | 0.73 |
Tobacco use | 3 (27) | 4 (40) | 0.74 |
Failed previous therapy (%) | |||
Topical/systemic antibiotics | 11 (100) | 10 (100) | |
Antiandrogens | 7 (64) | 6 (60) | |
Retinoids | 1 (9) | 0 (0) | |
Immunosuppressants/steroids | 8 (73) | 6 (60) | |
Minor excision/drainage | 11 (100) | 10 (100) | |
Disease characteristics | |||
Location (%) | |||
Axilla | 12 (41) | 13 (50) | |
Inguinal fold | 6 (21) | 2 (8) | |
Groin/genital/perineal | 5 (17) | 6 (23) | |
Breast | 4 (14) | 2 (8) | |
Other (trunk, neck, gluteal cleft) | 2 (7) | 3 (11) | |
No. affected sites | |||
Mean (range) | 2.6 (1–4) | 2.6 (1–5) | 0.71 |
Duration of symptoms, yr | |||
Mean (range) | 7.5 (2–26) | 7 (2–20) | 0.63 |